Ad
related to: primary prevention vs. secondary prevention in cardiology journal
Search results
Results from the WOW.Com Content Network
The journal's editor-in-chief is Prof Victor Aboyans (University of Limoges, France). It was established in 1994 as the European Journal of Cardiovascular Prevention & Rehabilitation and obtained its current title in 2012. It is currently published by Oxford University Press on behalf of the European Society of Cardiology.
Preventive healthcare strategies are described as taking place at the primal, [2] primary, [13] secondary, and tertiary prevention levels. Although advocated as preventive medicine in the early twentieth century by Sara Josephine Baker, [14] in the 1940s, Hugh R. Leavell and E. Gurney Clark coined the term primary prevention.
The quaternary prevention, concept coined by the Belgian general practitioner Marc Jamoulle, [1] [2] [3] Quaternary prevention is the set of health activities to mitigate or avoid the consequences of unnecessary or excessive intervention of the health system .
PREDIMED (Prevención con Dieta Mediterránea (Prevention with Mediterranean Diet [1])) was a large Spanish primary prevention trial which included 7,447 Spanish participants (55–80 years, 58% women) who were at high risk for cardiovascular disease, but otherwise healthy (initially free of cardiovascular disease).
Secondary prevention is discussed in myocardial infarction. [ 20 ] After a ban on smoking in all enclosed public places was introduced in Scotland in March 2006, there was a 17% reduction in hospital admissions for acute coronary syndrome. 67% of the decrease occurred in non-smokers.
The following outline is provided as an overview of and topical guide to cardiology, the branch of medicine dealing with disorders of the human heart. [1] The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology.
In contrast to primary dyslipidemias, secondary dyslipidemas are based on modifiable environmental or lifestyle factors. [10] Some diseases that are associated with a higher risk of dyslipidemia are uncontrolled diabetes mellitus , cholestatic liver disease, chronic kidney disease , hypothyroidism , and polycystic ovarian syndrome .
JUPITER was a randomized double-blind placebo-controlled study investigating the use of rosuvastatin in the primary prevention of cardiovascular disease.The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP).
Ad
related to: primary prevention vs. secondary prevention in cardiology journal